Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tdf Dtg'

Tdf Dtg published presentations and documents on DocSlides.

Use the Web Browser on Your Mobile Device to Participate in Polling*

Use the Web Browser on Your Mobile Device to Participate in Polling*

  • phoebe-click
  • 0 Slides

Go to: pollev.com/CCO2. or scan the QR code below...

What’s Next – and When:

What’s Next – and When:

  • sherrill-nordquist
  • 0 Slides

An Update on Injectable . P. revention. Alex R Ri...

Treating HIV Infection: HIV/AIDS Treatment

Treating HIV Infection: HIV/AIDS Treatment

  • celsa-spraggs
  • 0 Slides

A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...

Eric S. Daar , MD Professor of Medicine

Eric S. Daar , MD Professor of Medicine

  • faustina-dinatale
  • 0 Slides

David Geffen School of Medicine. at University of...

How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN

How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN

  • tawny-fly
  • 0 Slides

Sinead Delany-Moretlwe. Wits RHI, University of t...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Comparison of NNRTI vs NNRTI

Comparison of NNRTI vs NNRTI

  • lindy-dunigan
  • 0 Slides

ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH

  • kittie-lecroy
  • 32 Slides

Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

“On Demand” Oral PrEP: Lessons Learned from Macaque Models

  • giovanna-bartolotta
  • 13 Slides

“On Demand” Oral PrEP: Lessons Learned from M...

Gilead Sciences, Inc., Foster City, CA, USA

Gilead Sciences, Inc., Foster City, CA, USA

  • phoebe-click
  • 19 Slides

Gilead Sciences, Inc., Foster City, CA, USA FTC/T...

Common Pharmacomistakes in Advanced Illness

Common Pharmacomistakes in Advanced Illness

  • tawny-fly
  • 42 Slides

Common Pharmacomistakes in Advanced Illness Opioi...

CROI Update: Best of Boston

CROI Update: Best of Boston

  • triclin
  • 54 Slides

p. resented by. NCATEC. March . 18, . 2014. David ...

HIV Medicine From Guidelines to Practice

HIV Medicine From Guidelines to Practice

  • jubilantbikers
  • 63 Slides

Kiat. . Ruxrungtham. Professor of Medicine, . Chu...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

HIV Update Ardis Moe, M.D.

HIV Update Ardis Moe, M.D.

  • nonhurmer
  • 48 Slides

amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...

Evolving Options for HBV Therapy:

Evolving Options for HBV Therapy:

  • desiron
  • 39 Slides

Navigating the New Treatment Landscape. Outline. I...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

  • sportyinds
  • 10 Slides

, . prodrug. of . temsavir. . (. attachment inhi...

Comparison of RTV vs Cobi

Comparison of RTV vs Cobi

  • studmonkeybikers
  • 11 Slides

GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...

937401234123534671341849346744x 19 333133Webinar Requirements A c

937401234123534671341849346744x 19 333133Webinar Requirements A c

  • erica
  • 72 Slides

HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...

Selecting an Initial Antiretroviral Therapy (ART) Regimen

Selecting an Initial Antiretroviral Therapy (ART) Regimen

  • cappi
  • 30 Slides

www.hivguidelines.org. Purpose of . This Guideline...

Target Date Funds and P

Target Date Funds and P

  • unita
  • 12 Slides

lan . S. ponsor Responsibilities. Marcia S. Wagner...

Brad Hare Nothing to Disclose

Brad Hare Nothing to Disclose

  • beatrice
  • 17 Slides

Kaiser Permanente San Francisco Medical Center. Sa...

Renal and Bone Safety of

Renal and Bone Safety of

  • ashley
  • 16 Slides

Tenofovir. . Alafenamide. . vs. . Tenofovir. ....

Eric S. Daar , MD Michael S.

Eric S. Daar , MD Michael S.

  • ButterflyHeart
  • 41 Slides

Saag. , MD. Antiretroviral Therapy:. A Case-Based ...

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

  • alyssa
  • 7 Slides

302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...

Jeanne Marrazzo, MD, MPH

Jeanne Marrazzo, MD, MPH

  • rose
  • 9 Slides

Professor of Medicine. University of Washington. S...

Cabotegravir, Long-acting Injectable

Cabotegravir, Long-acting Injectable

  • jacey
  • 34 Slides

Last Updated: October 6, 2023. Prepared by:. David...

Retirement Plan Consulting

Retirement Plan Consulting

  • oconnor
  • 30 Slides

Overview of Services. Table of Contents. About RPA...

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

  • felicity
  • 8 Slides

ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...

Switching from TDF/FTC to TAF/

Switching from TDF/FTC to TAF/

  • fanny
  • 6 Slides

FTC. Study 311-1089. Switching from TDF/FTC to TAF...

NRTI-sparing SPARTAN PROGRESS

NRTI-sparing SPARTAN PROGRESS

  • shepard237
  • 5 Slides

RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

  • ricardo
  • 9 Slides

ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

  • micah
  • 16 Slides

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

  • matthew167
  • 11 Slides

NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...

Innovative Strategies for the Management

Innovative Strategies for the Management

  • karlyn-bohler
  • 37 Slides

of HIV Infection. Dual therapies without NRTIs. J...

Update on risk factors, detection, and management of neuroc

Update on risk factors, detection, and management of neuroc

  • natalia-silvester
  • 61 Slides

Scott Letendre, M.D.. Professor of . Medicine and...

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

  • calandra-battersby
  • 81 Slides

Adults:. . Implications . for Clinical Practice....

COMING SOON:

COMING SOON:

  • luanne-stotts
  • 31 Slides

GENERIC ARVs. Tim Horn. Treatment Action Group. t...

TDF Microsoft Lync - Novembre 2010

TDF Microsoft Lync - Novembre 2010

  • faustina-dinatale
  • 9 Slides

Solutions & Architectures UC . Polycom. - Mi...

CROI 2015: HIV Prevention Updates

CROI 2015: HIV Prevention Updates

  • pamella-moone
  • 24 Slides

Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...

Copyright © 2024 DocSlides. All Rights Reserved